Coferon logo — Pioneering the future of medicine with bioorthogonal linker...

Coferon

Pioneering the future of medicine with bioorthogonal linker chemistry for precise in-cell therapeutic assembly

Founded 2009 2-10 employees Debt Financing Total: $28.33M Biotechnology, Health and Wellness +1

General Information

Company Name Coferon
Founded Year 2009
Employees 2-10
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Coferon. To contact Coferon, visit coferon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Coferon compare?

A PDF of Coferon and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Coferon soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Coferon

Coferon is a biotech startup founded in 2009 and based in Stony Brook, New York. The company specializes in bioorthogonal linker chemistry and aims to revolutionize medicine by delivering therapeutic molecules in separate parts that self-assemble within target cells. Operating out of the Long Island High Tech Incubator on the Stony Brook University campus, Coferon is at the forefront of innovation in the biotechnology and pharmaceutical industries. The company's most recent investment was a $1.01M debt financing round on 11 August 2015. Although the specific investors for the latest round are not disclosed, Coferon's pioneering approach to in-cell therapeutic assembly positions it as a promising player in the biotech and pharmaceutical sectors.

Business keywords: biotech, bioorthogonal linker chemistry, therapeutic molecules, cellular therapy, drug delivery, Stony Brook University, Long Island High Tech Incubator

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $1.01M -
11 Aug 2015
Debt Financing $4.00M -
27 Oct 2014
Debt Financing $1.00M -
13 May 2014
Series B $12.00M 3
Hatteras Venture Partners, Ascent Biomedical Ventures +1
16 Jul 2012
Debt Financing $216.66K -
08 Dec 2011
Venture Round $3.00M -
16 May 2011
Debt Financing $7.10M -
06 Jan 2011

Coferon Alternatives & Competitors

View All Alternatives
Coferon vs

Tumor Activated Therapy: targeting Tumor Micro-Environment functional proteins to induce tumor self...

Seed
6 employees
Biotechnology, Health and Wellness
Coferon vs
Pana Bio, Inc
Pana Bio, Inc United States

A long-term, localized, and conditional delivery of the therapeutic molecules in vivo

0-1 employees
Biotechnology, Health and Wellness
Coferon vs

Custom AI systems for pharma and life-sciences

Seed
8 employees
AI, Biotechnology

FAQ About Coferon

Pioneering the future of medicine with bioorthogonal linker chemistry for precise in-cell therapeutic assembly
Coferon was founded in 2009.
Coferon operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on biotech, bioorthogonal linker chemistry, therapeutic molecules and cellular therapy.
Coferon has approximately 2-10 employees.
Coferon has completed 7 funding rounds, raising a total of $28.33M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Coferon include Seekyo Therapeutics, Pana Bio, Inc, Raven biosciences, Nanoligent, Evox Therapeutics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Coferon and Seekyo Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Coferon, https://bouncewatch.com/company/coferon, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes